Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: Role of Cigarette Smoking in Regulating Allergen-induced Early and Late Responses in Mild Asthmatics [EARLY_Phase 1]
A Phase 1 study examining whether cigarette smoking alters early and late allergen-induced responses in adults with mild asthma; the study s…
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: COX-2 Inhibition in Allergic Asthma [NA]
Clinical trial evaluating COX-2 inhibition in allergic asthma has completed; the provided snippet does not include results.
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With Asthma [Phase 2]
Phase 2 study assessing the bronchodilatory effect of a single dose QMF149 (indacaterol maleate/mometasone furoate) delivered via Twisthaler…
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: Safety and Tolerability of Indacaterol Maleate/Mometasone Furoate Delivered Via the Twisthaler® Device After 14 Days Treatment in Patients With Mild to Moderate Asthma [Phase 2]
A Phase 2 study assessing the safety and tolerability of the indacaterol maleate/mometasone furoate combination delivered via the Twisthaler…
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Risk of Asthma in Infants With Atopic Dermatitis
This clinical trial update discusses the risk of developing asthma in infants with atopic dermatitis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-04-10FDA Approved: PULMICORT RESPULES — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Pulmicort Respules (budesonide) from AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC) [Phase 3]
A Phase 3 trial (TALC) evaluated tiotropium bromide as an alternative to increasing inhaled corticosteroid dose for patients with asthma ina…
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: ENLaCE Pilot Study [NA]
Clinical Trial Update indicates that the ENLaCE Pilot Study in asthma has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Asthma and Quantifying Delivery Of Radio Labeled Aerosol [NA]
This clinical trial update reports the completion of a study evaluating the delivery of radiolabeled aerosol in asthma patients.
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: A Comparison of Management Strategies of Asthma in Pregnancy
This completed clinical trial compares different management strategies for asthma during pregnancy to identify effective approaches for cont…
-
FDA approval · 2013-04-04FDA Approved: CROMOLYN SODIUM — Original Application (Micro Labs Limited)
FDA approved Micro Labs Limited's original ANDA for cromolyn sodium.
-
CLINICAL_TRIALS trial_result · 2013-03-27Clinical Trial Update: A Study of Omalizumab in Preventing Bronchoconstriction Following Environmental Cat Dander Exposure in Patients With Cat Dander-induced Asthma [Phase 4]
Phase 4 trial evaluating omalizumab to prevent bronchoconstriction after cat dander exposure in patients with cat dander-induced asthma; res…
-
FDA approval · 2013-03-23FDA Approved: ALBUTEROL SULFATE HFA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Albuterol Sulfate HFA (Teva Pharmaceuticals USA, Inc.), indicating regulatory action to modify t…
-
EMA approval · 2013-03-22EMA Refused: Labazenit (Budesonide;salmeterol) — Laboratoires SMB S.A.
The EMA refused approval for Labazenit (budesonide; salmeterol) for asthma from Laboratoires SMB S.A., with a decision dated 22 March 2013.
-
FDA label_change · 2013-03-21FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) from Organon LLC, resulting in a labeling change for the product.
-
FDA approval · 2013-03-21FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC, resulting in changes to the product lab…
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of Indacaterol/Mometasone Delivered Via the TWISTHALER® Device in Adult Patients With Persistent Asthma [Phase 2]
Phase 2 results from a trial investigating the 24-hour FEV1 profile after a single dose of indacaterol/mometasone delivered via the TWISTHAL…
-
CLINICAL_TRIALS trial_result · 2013-03-20Clinical Trial Update: A Patient Advocate and Literacy-Based Treatment of Asthma [NA]
The completion of a clinical trial evaluating a literacy-based treatment approach for asthma, sponsored by the University of Pennsylvania. T…
-
FDA approval · 2013-03-14FDA Approved: XOPENEX HFA — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for XOPENEX HFA (levalbuterol tartrate) from Lupin Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Continuous Levalbuterol for Treatment of Status Asthmaticus in Children [Phase 4]
Phase 4 trial update evaluating continuous levalbuterol for treatment of status asthmaticus in children; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Real-world Effectiveness and Cost-effectiveness of Leading Inhaled Corticosteroids in Asthma Management
A completed real-world study assessing the effectiveness and cost-effectiveness of leading inhaled corticosteroids for asthma management.
-
CLINICAL_TRIALS research · 2013-03-11Clinical Trial Update: Enhancing Collaboration Between Doctors and Patients to Improve Asthma [NA]
A completed clinical trial from UCSF examining how enhanced collaboration between doctors and patients may improve asthma outcomes.
-
CLINICAL_TRIALS research · 2013-03-11Clinical Trial Update: Evaluating a Distance Learning Asthma Education Program for Pediatricians (The DALI Study) [NA]
A completed clinical trial evaluating a distance learning education program for pediatricians to improve asthma management.
-
CLINICAL_TRIALS research · 2013-03-11Clinical Trial Update: Optimal Approach for Analysis of Case-Control Genetic Association Studies
A clinical trial update discusses the optimal approach for analyzing case-control genetic association studies.
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a biomarker-based cockroach sublingual immunotherapy (BioCSI) for allergic rhinitis and asthma complet…